NEW YORK, May 30, 2023 /PRNewswire/ — Thorne HealthTech, Inc. (“Thorne”) (the “Company”) (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, announced today that it will participate in TD Cowen’s 7th Annual Future of the Consumer Conference in New York City. On Wednesday, June 7, at 10:45 a.m. … Read more
ANDOVER, Mass., May 30, 2023 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on May 24, 2023, TransMedics granted non-qualified stock options to purchase an aggregate of 87,472 shares of its common stock and … Read more
Data also shows that current standard-of-care testing for cancer patients falls short in multiple ways SAN DIEGO, May 30, 2023 /PRNewswire/ — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced some of the latest data on the impact of comprehensive genomic profiling (CGP) for oncology patients, which will … Read more
NEW YORK, May 30, 2023 /PRNewswire/ — Ceramedix, Inc., a privately-held biotherapeutics company developing a new class of antibody-based drugs designed with the aim to address novel disease targets involving the microvasculature, today announced it has joined Johnson & Johnson Innovation – JLABS (JLABS) as a resident company. Charles L. Dimmler, III, Executive Chairman of Ceramedix, … Read more
Completing Swimming Lessons, Supervising Children in the Water and Having Proper Gear All Keys to Safety CHANHASSEN, Minn., May 30, 2023 /PRNewswire/ — As temperatures soar and summer kicks off, Life Time, the nation’s premier healthy lifestyle brand, is gearing up for another fun and busy pool season at its more than 160 athletic country … Read more
CARMIEL, Israel, May 30, 2023 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today announced the following letter from its President and Chief Executive Officer, Dror Bashan, to its stockholders and … Read more
It was confirmed the presence of Prophage and Jamphage in the Alkalihalobacillus clausii Prophage and Jamphage are expected to play a substantial role in bacterial survival and immune regulation in the body. BOSTON and SEOUL, South Korea, May 29, 2023 /PRNewswire/ — iNtRON Biotechnology (“iNtRON”, www.intodeworld.com) has announced today the identification of Prophage and (non-) … Read more
SEONGNAM, South Korea and CAMBRIDGE, Mass., May 29, 2023 /PRNewswire/ — Bridge Biotherapeutics Inc. (KQ288330), a South Korean clinical-stage biotechnology company focused on developing novel drugs for cancer, fibrosis and inflammation, is scheduled to give a company presentation on Tuesday, June 6 at the 2023 BIO International Convention taking place in Boston, Massachusetts, between June … Read more
– Nuvaxovid™ de Novavax recibe la opinión positiva del CHMP para la autorización de comercialización completa para la prevención de la COVID en la UE GAITHERSBURG, Md., 29 de mayo de 2023 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), una compañía global que promueve vacunas basadas en proteínas con su novedoso adyuvante Matrix-M™, anunció hoy que … Read more
GAITHERSBURG, Maryland, 29 mai 2023 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), une entreprise mondiale qui fait progresser les vaccins à base de protéines avec son nouvel adjuvant Matrix-M™, a annoncé aujourd’hui que Nuvaxovid™ (NVX-CoV2373) a été recommandé pour une autorisation de mise sur le marché (AMM) complète pour une utilisation en tant que série primaire … Read more